🔎 Trials Near Me

Home › Chronic Pain › NCT06128772

Utilizing Battlefield Acupuncture to Treat Chronic Pain

Recruiting

A Randomized Clinical Trial Utilizing Battlefield Acupuncture to Treat Chronic Pain in Veterans With a History of Substance Use Disorder.

Who can join

Ages 18 and older · All sexes

Full eligibility criteria
Inclusion Criteria: Eligibility criteria include:

* they are 18 years or older
* they have a history of substance use disorder,
* history of chronic pain
* availability to participate in the study for 16 weeks.

Exclusion Criteria:

* female veterans who are pregnant.
* history of bleeding disorders or currently on older blood thinning medications that cause excessive bleeding.
* currently being treated for an active infection of the outer ear (relative contraindication). -- currently have a PICC line in their body or are receiving IV antibiotics.
* fear of needles/tacks, and/or
* undiagnosed pain complaint

About the study

This research study will evaluate the effectiveness of utilizing Battlefield Acupuncture (BFA) on veterans with with a history of substance use disorder and chronic pain for 8 weeks.

Primary Aim: The primary aim of this study is to evaluate the effectiveness of using BFA to treat chronic pain in veterans with a history of substance use disorder.

Secondary Aim: This study will also evaluate the impact that BFA treatment for pain may have on subjects' stress, mood and sleep patterns over 8 weeks. In addition, each subject will be complete behavioral research tools to measure: depression, anxiety, and substance use at 3 different points in this study.

Hypothesis: The use of BFA on veterans with chronic pain will decrease their pain and substance use and improve their quality of life.

What is being tested

Sponsor: Edith Nourse Rogers Memorial Veterans Hospital · Participants: 125 · Started: Dec 30, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT06128772

Locations in the U.S.

MassachusettsBedford VA Healthcare System, Bedford

Conditions

From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.